Free Trial
NASDAQ:BTCY

Biotricity 6/29/2023 Earnings Report

Biotricity logo
$0.53 +0.03 (+6.44%)
As of 05/29/2025 03:38 PM Eastern

Biotricity EPS Results

Actual EPS
-$0.54
Consensus EPS
-$0.54
Beat/Miss
Met Expectations
One Year Ago EPS
N/A

Biotricity Revenue Results

Actual Revenue
$2.74 million
Expected Revenue
$2.60 million
Beat/Miss
Beat by +$140.00 thousand
YoY Revenue Growth
N/A

Biotricity Announcement Details

Quarter
Time
N/A
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Biotricity's next earnings date is estimated for Wednesday, June 25, 2025, based on past reporting schedules.

Conference Call Resources

Biotricity Earnings Headlines

Trump Knows Exactly What He's Doing
REVEALED: $194 Trillion Trump Market Pattern Trump fires off a tweet and stocks tank… He gives a speech and the markets soar… Now, a new Trump executive order is set to set off a wave worth a potential $194 trillion in the markets. And Wall Street insider Larry Benedict says it could hand investors who missed out on Trump’s first term a second chance.
See More Biotricity Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Biotricity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biotricity and other key companies, straight to your email.

About Biotricity

Biotricity (NASDAQ:BTCY), a medical technology company, provides biometric data monitoring solutions in the United States. The company focuses on delivery of remote monitoring solutions to medical, healthcare, and consumer markets, including diagnostic and post-diagnostic solutions for lifestyle and chronic illnesses. It offers Bioflux mobile cardiac telemetry solution, an integrated ECG device; and ECG analysis software that analyzes and synthesizes patient ECG monitoring data, as well as software components. The company is based in Redwood City, California.

View Biotricity Profile

More Earnings Resources from MarketBeat